Secukinumab s.c. injection
CAIN457A02001B
Approved mab active
Quick answer
Secukinumab s.c. injection for Autoimmunity, Inflammation is a Approved program (mab) at Novartis Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Novartis Pharmaceuticals
- Indication
- Autoimmunity, Inflammation
- Phase
- Approved
- Modality
- mab
- Status
- active